Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s McClellan Touts Scientific Analysis As Part Of Ephedra Ban

Jan 26 2004

• By The Tan Sheet

Related Content

FDA Regulatory Framework For Ephedra Ban Expected To Get Court Review

Jan 05 2004

Aristolochia Renal Disease Link Reported In Two U.S. Cases

Apr 16 2001

Syntrax LipoKinetix Liver AERs Necessitate Product Removal – FDA

Nov 26 2001

Additional Topics

OTC Drugs Consumer

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window